Skip to content

Moxibustion treatment in Osteoarthritis of the Knee: a randomized double-blinding control trial

Moxibustion treatment in Osteoarthritis of the Knee: a randomized double-blinding control trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001408
Enrollment
Unknown
Registered
2011-07-01
Start date
2009-09-06
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

1:applying true moxa cone on the points ST35, EX-LE4 and Ashi point around the knees, three moxa cone every point, once a day, three times a week for six weeks, total 18 times.
2:applying sham moxa cones on the points ST35, EX-LE4 and Ashi point around the knees, three moxa cone every point,once a day, three times a week for six weeks, total 18 times.

Sponsors

Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male and female aged 45 to 75 years old; 2. Able and willing to provide signed informed consent; 3. Have a diagnosis of osteoarthritis of the knee (fulfilling ACR criteria) for at least 6 months; 4. have at least moderate pain in the knee for most days of the past month; 5. be taking analgesic or nonsteroidal anti-inflammatory agents (NSAIDs), but not corticosteroids, but will be asked to document use; 6. have documented radiographic osteoarthritis changes (Kellgren-Lawrence grade>2).

Exclusion criteria

Exclusion criteria: 1. corticosteroid treatment within the past 3 months; 2. intra-articular (IA) injection within the past 6 months; 3. joint lavage or joint endoscopy examination within the past year; 4. uncontrolled medical condition,which could affect the trial, such as cancer; 5. use of any investigational drug within the past 30 days; 6. bleeding tendency,including the use of anticoagulants; 7. other arthritis such as rheumatoid arthritis; 8. participating other trials at the same time; 9. former knee joint surgery; 10. prior experience with moxibustion treatment; 11. allergy to moxa smoke; 12. applying local exteranl therapy, e.g. local pasting with chinese medication 13. unable to fulfil the forms.

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster Universities' Osteoarthritis Index (WOMAC) score;

Secondary

MeasureTime frame
patient global assessment;36-Item Short-Form Health Survey (SF-36);

Countries

China

Contacts

Public ContactXueyong Shen
snowysh@hotmail.com+86 13361838083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026